Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 537

5.

Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.

Pan CC, Chen PC, Chou TY, Chiang H.

Hum Pathol. 2003 Nov;34(11):1155-62.

PMID:
14652817
6.

Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.

Lucas DR, Pass HI, Madan SK, Adsay NV, Wali A, Tabaczka P, Lonardo F.

Histopathology. 2003 Mar;42(3):270-9.

PMID:
12605647
8.

Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.

Attanoos RL, Dojcinov SD, Webb R, Gibbs AR.

Histopathology. 2000 Sep;37(3):224-31.

PMID:
10971698
9.

The value of 'mesothelium-associated' antibodies in distinguishing between metastatic renal cell carcinomas and mesotheliomas.

Osborn M, Pelling N, Walker MM, Fisher C, Nicholson AG.

Histopathology. 2002 Oct;41(4):301-7.

PMID:
12383211
12.
13.

Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.

Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K.

Pathol Int. 2007 Apr;57(4):190-9.

PMID:
17316414
14.
16.
17.

Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.

Ordóñez NG, Sahin AA.

Hum Pathol. 2014 Jul;45(7):1529-40. doi: 10.1016/j.humpath.2014.03.006. Epub 2014 Mar 27.

PMID:
24816068
18.
20.

Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis.

Carella R, Deleonardi G, D'Errico A, Salerno A, Egarter-Vigl E, Seebacher C, Donazzan G, Grigioni WF.

Am J Surg Pathol. 2001 Jan;25(1):43-50.

PMID:
11145250

Supplemental Content

Support Center